Clinical trial participant’s autopsy and brain exam stoke Alzheimer’s drug fears

Amyloid-clearing antibody lecanemab faces key FDA hearing in June

Clinical trial participant’s autopsy and brain exam stoke Alzheimer’s drug fears Read More »